[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053231":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":256,"collaborators":25,"id":258,"slug":259,"hasResults":260,"nctId":261,"briefTitle":262,"officialTitle":263,"acronym":25,"eligibilityCriteria":264,"healthyVolunteers":260,"sex":265,"minAge":266,"maxAge":25,"enrollmentInfo":267,"targetDuration":25,"studyType":270,"phases":271,"briefSummary":273,"conditions":274,"keywords":276,"overallStatus":37,"whyStopped":25,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":282,"startDateStruct":285,"completionDateStruct":287,"leadSponsor":289,"locationsCount":290},{"fullName":5,"class":6},"Akebia Therapeutics","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Praliciguat","EXPERIMENTAL","Praliciguat will be administered daily with dose escalation to a target dose during a 24-week double-blind period, followed by a 24-week open-label treatment period.",[13],"Drug: Praliciguat",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Matching placebo will be administered daily for 24 weeks",[19],"Other: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Oral Tablet",[9],null,{"type":27,"name":15,"description":23,"armGroupLabels":28,"otherNames":25},"OTHER",[15],[30],{"name":5,"role":31,"phone":32,"phoneExt":25,"email":33},"CONTACT","16178446128","trials@akebia.com",[35,49,58,67,77,87,96,105,114,124,135,145,155,164,174,184,194,203,213,223,233,242,248],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":25},"Investigator Site #2","RECRUITING","Chula Vista","California","91910","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-117.0842,32.64005,{"lat":47,"lon":46},{"facility":50,"status":37,"city":51,"state":39,"zip":52,"country":41,"countryCode":42,"cosmosGeoPoint":53,"geoPoint":57,"contacts":25},"Investigator Site #14","Los Angeles","90022",{"type":44,"coordinates":54},[55,56],-118.24368,34.05223,{"lat":56,"lon":55},{"facility":59,"status":37,"city":60,"state":39,"zip":61,"country":41,"countryCode":42,"cosmosGeoPoint":62,"geoPoint":66,"contacts":25},"Investigator Site #12","San Dimas","91773",{"type":44,"coordinates":63},[64,65],-117.80673,34.10668,{"lat":65,"lon":64},{"facility":68,"status":37,"city":69,"state":70,"zip":71,"country":41,"countryCode":42,"cosmosGeoPoint":72,"geoPoint":76,"contacts":25},"Investigator Site #13","Arvada","Colorado","80002",{"type":44,"coordinates":73},[74,75],-105.08748,39.80276,{"lat":75,"lon":74},{"facility":78,"status":37,"city":79,"state":80,"zip":81,"country":41,"countryCode":42,"cosmosGeoPoint":82,"geoPoint":86,"contacts":25},"Investigator Site #17","Boca Raton","Florida","33431",{"type":44,"coordinates":83},[84,85],-80.0831,26.35869,{"lat":85,"lon":84},{"facility":88,"status":37,"city":89,"state":80,"zip":90,"country":41,"countryCode":42,"cosmosGeoPoint":91,"geoPoint":95,"contacts":25},"Investigator Site #6","Coral Springs","33071",{"type":44,"coordinates":92},[93,94],-80.2706,26.27119,{"lat":94,"lon":93},{"facility":97,"status":37,"city":98,"state":80,"zip":99,"country":41,"countryCode":42,"cosmosGeoPoint":100,"geoPoint":104,"contacts":25},"Investigator Site #7","Miami","33172",{"type":44,"coordinates":101},[102,103],-80.19366,25.77427,{"lat":103,"lon":102},{"facility":106,"status":37,"city":107,"state":80,"zip":108,"country":41,"countryCode":42,"cosmosGeoPoint":109,"geoPoint":113,"contacts":25},"Investigator Site #8","Orlando","32806",{"type":44,"coordinates":110},[111,112],-81.37924,28.53834,{"lat":112,"lon":111},{"facility":115,"status":37,"city":116,"state":117,"zip":118,"country":41,"countryCode":42,"cosmosGeoPoint":119,"geoPoint":123,"contacts":25},"Investigator Site # 1","Lawrenceville","Georgia","30046",{"type":44,"coordinates":120},[121,122],-83.98796,33.95621,{"lat":122,"lon":121},{"facility":125,"status":126,"city":127,"state":128,"zip":129,"country":41,"countryCode":42,"cosmosGeoPoint":130,"geoPoint":134,"contacts":25},"Investigator Site #3","TERMINATED","Chicago","Illinois","60643",{"type":44,"coordinates":131},[132,133],-87.65005,41.85003,{"lat":133,"lon":132},{"facility":136,"status":37,"city":137,"state":138,"zip":139,"country":41,"countryCode":42,"cosmosGeoPoint":140,"geoPoint":144,"contacts":25},"Investigator Site #11","Louisville","Kentucky","40205",{"type":44,"coordinates":141},[142,143],-85.75941,38.25424,{"lat":143,"lon":142},{"facility":146,"status":37,"city":147,"state":148,"zip":149,"country":41,"countryCode":42,"cosmosGeoPoint":150,"geoPoint":154,"contacts":25},"Investigator Site #15","Livonia","Michigan","48152",{"type":44,"coordinates":151},[152,153],-83.35271,42.36837,{"lat":153,"lon":152},{"facility":156,"status":37,"city":157,"state":148,"zip":158,"country":41,"countryCode":42,"cosmosGeoPoint":159,"geoPoint":163,"contacts":25},"Investigator Site #10","Pontiac","48341",{"type":44,"coordinates":160},[161,162],-83.29105,42.63892,{"lat":162,"lon":161},{"facility":165,"status":37,"city":166,"state":167,"zip":168,"country":41,"countryCode":42,"cosmosGeoPoint":169,"geoPoint":173,"contacts":25},"Investigator Site #16","New Bern","North Carolina","28562",{"type":44,"coordinates":170},[171,172],-77.04411,35.10849,{"lat":172,"lon":171},{"facility":175,"status":37,"city":176,"state":177,"zip":178,"country":41,"countryCode":42,"cosmosGeoPoint":179,"geoPoint":183,"contacts":25},"Investigator Site #20","Cleveland","Ohio","44106",{"type":44,"coordinates":180},[181,182],-81.69541,41.4995,{"lat":182,"lon":181},{"facility":185,"status":37,"city":186,"state":187,"zip":188,"country":41,"countryCode":42,"cosmosGeoPoint":189,"geoPoint":193,"contacts":25},"Investigator Site #19","Bridgeville","Pennsylvania","15017",{"type":44,"coordinates":190},[191,192],-80.11006,40.35618,{"lat":192,"lon":191},{"facility":195,"status":37,"city":196,"state":187,"zip":197,"country":41,"countryCode":42,"cosmosGeoPoint":198,"geoPoint":202,"contacts":25},"Investigator Site #22","Butler","16001",{"type":44,"coordinates":199},[200,201],-79.89533,40.86118,{"lat":201,"lon":200},{"facility":204,"status":37,"city":205,"state":206,"zip":207,"country":41,"countryCode":42,"cosmosGeoPoint":208,"geoPoint":212,"contacts":25},"Investigator Site #23","Goose Creek","South Carolina","29445",{"type":44,"coordinates":209},[210,211],-80.03259,32.98101,{"lat":211,"lon":210},{"facility":214,"status":37,"city":215,"state":216,"zip":217,"country":41,"countryCode":42,"cosmosGeoPoint":218,"geoPoint":222,"contacts":25},"Investigator Site #4","Chattanooga","Tennessee","37404",{"type":44,"coordinates":219},[220,221],-85.30968,35.04563,{"lat":221,"lon":220},{"facility":224,"status":37,"city":225,"state":226,"zip":227,"country":41,"countryCode":42,"cosmosGeoPoint":228,"geoPoint":232,"contacts":25},"Investigator Site #5","Arlington","Texas","76015",{"type":44,"coordinates":229},[230,231],-97.10807,32.73569,{"lat":231,"lon":230},{"facility":234,"status":37,"city":235,"state":226,"zip":236,"country":41,"countryCode":42,"cosmosGeoPoint":237,"geoPoint":241,"contacts":25},"Investigator Site #21","Dallas","75230",{"type":44,"coordinates":238},[239,240],-96.80667,32.78306,{"lat":240,"lon":239},{"facility":243,"status":37,"city":235,"state":226,"zip":244,"country":41,"countryCode":42,"cosmosGeoPoint":245,"geoPoint":247,"contacts":25},"Investigator Site #9","75231",{"type":44,"coordinates":246},[239,240],{"lat":240,"lon":239},{"facility":249,"status":37,"city":250,"state":226,"zip":149,"country":41,"countryCode":42,"cosmosGeoPoint":251,"geoPoint":255,"contacts":25},"Investigator Site #18","Houston",{"type":44,"coordinates":252},[253,254],-95.36327,29.76328,{"lat":254,"lon":253},{"type":257,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100053231","phase-2-a-study-of-praliciguat-in-participants-with-focal-segmental-glomerulosclerosis-fsgs-100053231",false,"NCT07268638","A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)","A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Praliciguat in Patients With Biopsy-Confirmed Focal Segmental Glomerulosclerosis","Inclusion Criteria:\n\n1. UPCR ≥1 (g\u002Fg) during screening.\n2. On maximally tolerated ACEi or ARB per principal investigator discretion within 1 month of informed consent.\n3. Estimated glomerular filtration rate ≥25 milliliters per minute per 1.73 square meters by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.\n4. Kidney biopsy collected within 5 years of screening consistent with FSGS or kidney biopsy collected ≥5 years prior to screening consistent with FSGS plus the presence of a pathogenic gene mutation known to be associated with FSGS.\n\nExclusion Criteria:\n\n1. Collapsing FSGS in the kidney biopsy report.\n2. Sickle cell disease.\n3. HbA1c \\>8%.\n4. Uncontrolled hypertension (≥160\u002F100 millimeters of mercury).","ALL","18 Years",{"count":268,"type":269},60,"ESTIMATED","INTERVENTIONAL",[272],"PHASE2","This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adults with biopsy-confirmed focal segmental glomerulosclerosis (FSGS). Participants will be randomized 1:1 to receive praliciguat or placebo for initial 24 week treatment period. Following this double-blind period, all participants will receive praliciguat in an open-label extension for an additional 24 weeks.",[275],"Focal Segmental Glomerulosclerosis",[277,278,279,280],"Glomerular Disease","Chronic Kidney Disease","Proteinuria","Urine protein-to-creatinine ratio","2026-07-10",{"date":283,"type":284},"2026-07-13","ACTUAL",{"date":286,"type":284},"2025-12-03",{"date":288,"type":269},"2028-01",{"name":5,"class":6},23]